Company Completes Historic Trial Enrollment, Secures Transformational Financing, and Sees Promising ...

Positive Initial 6-Month Data from First 10 Patients and Improvements in Speech Understanding and Qu...

All 56 Enrolled Subjects Have Been Through Their Activation Visit Firming Up Study Timeline

Proven Med Tech Leader with an Established Track Record of Commercial Success and Optimizing Shareho...

Company Remains on Schedule for PMA Submission to FDA White Bear Lake, Minnesota--(Newsfile Corp. - ...

Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to ...

First Cochlear Implant Company to Announce Completed Enrollment of a U.S. Pivotal Clinical Trial for...

White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH...

White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH...

Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy ...